Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AACADIA PHARMACEUTICALS INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

ACADIA PHARMACEUTICALS INC

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
    Sep 24, 2026Acadia Pharmaceuticals Press Releases
  • European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
    Aug 24, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
    Aug 4, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
    Jul 30, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
    Jul 20, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
    Jul 15, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
    Jul 6, 2026Acadia Pharmaceuticals Press Releases
  • DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
    Jun 26, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
    May 6, 2026Acadia Pharmaceuticals Press Releases
  • Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
    Apr 30, 2026Acadia Pharmaceuticals Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
$20.03Close · Oct 6, 2026